January 4, 2023Open Access

Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma

SHShawn L. Hervey‐JumperUniversity of California, San Francisco YZYalan ZhangFujian Medical University JPJoanna J. PhillipsUniversity of California, San Francisco

Key Points

Key points are not available for this paper at this time.

Abstract

Across both subtypes of LGG, EOR beginning at 75% improves OS while beginning at 80% improves progression-free survival. Nonetheless, maximal resection with preservation of neurological function remains the treatment goal. Our findings have implications for surgical strategies for LGGs, particularly oligodendroglioma.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Hervey‐Jumper et al. (Wed,) studied this question.

synapsesocial.com/papers/69d98ec4a1d151c65f68480e https://doi.org/https://doi.org/10.1200/jco.21.02929

Demander à l'IA

Bookmark

View Full Paper